Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial
Circulation: Cardiovascular Interventions · 2024-10 · 17 (10)
DOI: 10.1161/circinterventions.124.014529 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2024-10. Verfasst von Adam C Bland und 21 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Gosford Hospital, Central Coast Local Health District, Australia (A.C.B., W.M., P.M., E.C., E.R., N.H., A.P., S.L.S., A.K., T.…. Hauptthemen laut MEDLINE: Radial Artery, Percutaneous Coronary Intervention, Coronary Angiography, Equipment Design. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 17 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The 1.5 mm Baby J hydrophilic narrow J-tipped wire is a development of the standard 0.035” 3-mm J-tipped peripheral guidewire, designed to improve efficiency of transradial coronary procedures by safely navigating small caliber radial arteries to the aorta. There is currently a lack of evidence comparing the procedural success and safety of different peripheral guidewires used in transradial cardiac procedures. We compared the efficacy and safety of a narrow J-tipped hydrophilic 0.035” wire (intervention, Radifocus Baby J guidewire; TERUMO Co, Tokyo, Japan) versus a standard fixed-core 0.035” J wire (control). METHODS: Investigator-initiated, blinded, Australian, multicenter randomized trial in patients undergoing clinically indicated coronary angiography or percutaneous coronary intervention. Patients were randomized 1:1 to use either the control guidewire or the intervention guidewire. The primary end point (technical success) was defined as gaining aortic root access with the randomized guidewire. RESULTS: In all, 330 patients were randomized between October 2022 and June 2023 (median age was 69 years, 36% were female, and body mass index was 29 kg/m 2 ). The primary end point was achieved more frequently in the intervention group (96% versus 84%; absolute risk reduction 12% [95% CI, 5.7–18.3]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Gosford Hospital, Central Coast Local Health District, Australia (A.C.B., W.M., P.M., E.C., E.R., N.H., A.P., S.L.S., A.K., T.K., A.H., R.S., K.S., A.M., M.P., M.I., M.W., P.J., T.J.F.).
- School of Medicine and Public Health, The University of Newcastle, Australia (A.C.B., S.L.S., N.C., A.B., M.W., T.J.F.).
- Cardiology Department, John Hunter Hospital, Hunter New England Local Health District, Newcastle, Australia (D.F., N.C., A.B.).
ORCID-Profile: Adam C Bland, Philopatir Mikhail, Eunice Chuah, Eleanor Redwood, David Ferreira, Adam Perkovic, Samantha L Saunders, Amy Kelty, Michael Parkinson, Andrew Boyle, Prajith Jeyaprakash, Tom J Ford
Zitieren
APA
Bland, A. C., Meere, W., Mikhail, P., Chuah, E., Redwood, E., Ferreira, D., Howden, N., Perkovic, A., Saunders, S. L., Kelty, A., Kull, T., Hill, A., Spina, R., Sarathy, K., May, A., Parkinson, M., Ishak, M., Collins, N., Boyle, A., …, & Ford, T. J. (2024). Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial. Circulation: Cardiovascular Interventions, 17(10). https://doi.org/10.1161/circinterventions.124.014529
Vancouver
Bland AC, Meere W, Mikhail P, Chuah E, Redwood E, Ferreira D, et al. Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial. Circulation: Cardiovascular Interventions. 2024;17(10). doi:10.1161/circinterventions.124.014529
BibTeX
@article{Bland2024,
author = {Bland, Adam C and Meere, William and Mikhail, Philopatir and Chuah, Eunice and Redwood, Eleanor and Ferreira, David and Howden, Nicklas and Perkovic, Adam and Saunders, Samantha L and Kelty, Amy and Kull, Tony and Hill, Andrew and Spina, Roberto and Sarathy, Kiran and May, Austin and Parkinson, Michael and Ishak, Mark and Collins, Nicholas and Boyle, Andrew and William, Maged and Jeyaprakash, Prajith and Ford, Tom J},
title = {Enhancing Guidewire Efficacy for Transradial Access: The EAGER Randomized Controlled Trial},
journal = {Circulation: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {10},
doi = {10.1161/circinterventions.124.014529}
}
EUVIMED